NL-OMON20251
Completed
Not Applicable
Enhancement of exposure therapy for social anxiety disorder with testosterone: A proof-of-concept randomized placebo-controlled trial
Prof. dr. Karin Roelofs-Radboud University Nijmegen, Behavioural Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Postbus 9101, 6500 HB Nijmegen-Leiden University, Faculty of Social and BehaviouralSciences, Institute of PsychologyWassenaarseweg 52, 2333 AK LeidenK.roelofs@donders.ru.nl0 sites52 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Social anxiety disorderSpeach anxietyExposure therapySociale angststoornisSpreekangstExposure behandeling
- Sponsor
- Prof. dr. Karin Roelofs-Radboud University Nijmegen, Behavioural Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Postbus 9101, 6500 HB Nijmegen-Leiden University, Faculty of Social and BehaviouralSciences, Institute of PsychologyWassenaarseweg 52, 2333 AK LeidenK.roelofs@donders.ru.nl
- Enrollment
- 52
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Woman, 18\-45 years old
- •\- Social Anxiety Disorder (SAD) as established with a structured interview (MINI), and with speech anxiety as primary fear
Exclusion Criteria
- •\- Prior non response to exposure therapy (i.c. speech exposure) for SAD symptoms, as defined by the patient’s report of receiving specific and regular exposure assignments as part of previous therapy.
- •\- Entry of patients with other mood or anxiety disorders will be permitted in order to increase accrual of a clinically relevant sample; however in cases where SAD is not judged to be the predominant disorder, participants will not be eligible.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Enhancement of exposure therapy for social anxiety disorder with testosterone: A randomized placebo controlled clinical trialperformance anxietysocial anxiety disordersocial phobiaspeech anxiety10002861NL-OMON44812ProPersona (Nijmegen)54
Active, not recruiting
Phase 1
Testosterone and exposure therapy for SADEUCTR2014-004475-23-NLRadboud University Nijmegen
Terminated
Not Applicable
Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current StimulationSocial AnxietyNCT03743571University of Nevada, Reno33
Recruiting
Not Applicable
Optimizing exposure in the treatment of anxiety in youth: Facing fears in-session or out-session?NL-OMON45412Rijksuniversiteit Groningen60
Recruiting
Not Applicable
Optimizing exposure in the treatment of anxiety in youth: Facing fears in big or small steps?specific fearSpecific phobia10002861NL-OMON49153Rijksuniversiteit Groningen50